Image

Surufatinib Plus Camrelizumab and AS in First Line Treatment of Advanced Metastatic Pancreatic Cancer

Investigational Treatment Research Study for Advanced Metastatic Pancreatic Cancer

Recruiting
18-75 years
All
Phase 1/2
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study investigates advanced metastatic pancreatic cancer. It evaluates the use of an investigational medication in combination with other treatments.

The study focuses on evaluating the safety and effectiveness of the investigational combination treatment for patients with this condition.

  • Who can participate: Adults aged 18 to 75 with advanced pancreatic cancer who have not received prior systemic therapy are eligible. Participants must have an ECOG performance status of 0-1 and meet certain health criteria.
  • Study details: Participants will receive either the investigational treatment or a standard treatment. The study includes a placebo, which is an inactive substance that looks like the investigational medicine but does not contain any medicine.
Print
Study details
    Pancreatic Cancer
    PDAC - Pancreatic Ductal Adenocarcinoma
    Pancreas Cancer
    Pancreatic Neoplasms

NCT05218889

Chinese PLA General Hospital

31 July 2026

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.